Tranexamic acid in trauma patients

In this large multi-center randomized trial of adult trauma patients with or at high risk for bleeding, they were randomized to tranexamic acid (8 hour infusion) or placebo. All-cause mortality and mortality due to bleeding were both significantly lower in those who received tranexamic acid. The use of tranexamic acid should be considered in patients with trauma-related bleeding (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment